Vigabatrin
- TRADE NAME: Sabril (Lundbeck)
- INDICATIONS: Epilepsy; infantile spasms (West's syndrome)
- CLASS: Anticonvulsant, Antiepileptic
- HALF-LIFE: 7.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Antipsychotics, Chloroquine, Hydroxychloroquine, MAO inhibitors, Mefloquine, Orlistat, Phenytoin, Rufinamide, SSRIs, St John's Wort, Tricyclic antidepressants
PREGNANCY CATEGORY: C
VISION LOSS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.
Page last updated 08/14/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric